10/26/2021
Cleveland Clinic Launches First-of-its-Kind Preventative Breast Cancer Vaccine Study
Cleveland Clinic has begun clinical testing of a novel vaccine designed ultimately to prevent triple-negative breast cancer (TNBC) by priming high-risk women to mount an immune response against a “retired” lactation protein expressed only in cancer cells
10/22/2021
Allegheny Health Network Vascular Surgeons First in Pennsylvania to Use Groundbreaking Surgical GPS-like Navigation System, Advancing Care for Complex Aortic Aneurysms
A team of vascular surgeons at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN), is one of the first in the country to advance the care of complex aortic aneurysms by utilizing a cutting-edge intra-operative positioning system (IOPS) by Centerline Biomedical. The minimally invasive, technology platform creates three-dimensional perspectives of the vascular system to improve navigation, quickly locate aortic aneurysms and precisely implant stent grafting to perform complex endovascular aortic interventions.
10/20/2021
Deep Brain Stimulation Shows Promising Results for Stroke Patients, Study Finds
Results from a Cleveland Clinic study, which has been years in the making, show the benefits of deep brain stimulation for people who have had a stroke. Andre Machado, MD, PhD, who is Chairman of the Neurological Institute, helped lead the study. “We evaluated, for the first time, if we could use a modified type of deep brain stimulation, a modified type of brain pacemaker, going into an area of the brain called the cerebellum, to help people recover from the weakness that resulted from a prior stroke,” explained Dr. Machado.
10/19/2021
Trinity Health Invests in Xealth to Accelerate Digital Health
HLTH Conference — Xealth, the leader in enabling digital health at scale, today announced that Trinity Health, one of the nation’s largest Catholic health care systems, has invested in the company. Trinity is one of 15 health system investors for the company, bringing the total Series B funding to $25 million. This support demonstrates continued provider consensus in adopting digital health in a way that best engages both clinicians and patients.
10/19/2021
Cleveland Clinic Surgical Team Performs First Right-Sided Robotic Liver Resection
Traditional liver surgery is performed through one open incision incision below the ribs or along the midline and takes a significant amount of recovery. Over the past 10 years, minimally invasive liver resection has emerged as a viable alternative. This robotic-assisted right-sided hepatectomy was the first one performed at Cleveland Clinic.
10/11/2021
Opening of Cleveland Clinic BioRepository Expands Infrastructure for Pursuit of Personalized Medicine
Cleveland Clinic and Brooks Automation have opened the Cleveland Clinic BioRepository to increase the storage capacity for biological samples at Cleveland Clinic while enhancing researchers’ study of human tissue samples to more rapidly translate laboratory discoveries into new treatments for patients.
09/21/2021
Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health
Xealth, the leader in enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health. Seven additional health systems – Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and Stanford Health Care – join existing health system investors Atrium Health, Cleveland Clinic, Froedtert & MCW Health Network, MemorialCare Innovation Fund, Providence and UPMC. This brings the company’s total funding to date to $52.6 million.
09/14/2021
Cleveland Diagnostics Presents New Data Supporting the Clinical Validation and Clinical Utility of ISoPSA
Cleveland Diagnostics, Inc., a commercial stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that Eric Klein, MD, Chairman of the Glickman Urological & Kidney Institute at Cleveland Clinic, delivered two presentations at the annual meeting of the American Urological Association regarding the company’s prostate cancer test, IsoPSA
09/07/2021
Bionic Arm's Neurorobotic Sensory-Motor Fusion Restores Natural Behaviors
In a new study published in Science Robotics, a Cleveland Clinic-led research team reports that it has engineered a first-of-its-kind neurorobotic prosthetic arm for patients with upper-limb amputations that allows wearers to think, behave and function more like a person without an amputation.
07/28/2021
New VR Platform Fuses Physical and Virtual Worlds in Parkinson's Disease and Beyond
Recently scientists at Cleveland Clinic have developed a solution to the locomotion problem and have created a truly immersive VR experience. They are initiating research to use their platform to understand and better treat freezing of gait in patients with Parkinson’s disease (PD). Future research plans include use of the platform for early identification of PD and other neurodegenerative disorders in older adults.